Fresenius SE's restructuring and dividend reinstatement signal strong growth. Read why FSNUF stock may not be a long-term buy ...
March 4 (Reuters) - Dialysis firm Fresenius Medical Care (FMEG.DE), opens ... 2025 Healthcare & Pharmaceuticalscategory US FDA greenlights GSK's drug for UTIs in women and girls March 25, 2025 ...
Hosted on MSN26d
'Tariff taskforce': Pharma firms scramble to prepare even as Trump levies risk flouting WTO rulesEurope's pharmaceutical firms are rushing to prepare ... warn that levies on the sector could break global trade rules. Fresenius Medical Care says that it has installed its first-ever "tariff ...
Vifor Pharma has forged a strategic partnership with Fresenius Kabi ... Researchers in the US have devised a new depot system that could provide months or even years of delivery from a single ...
Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 ...
mAbxience is a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma. Fresenius Kabi is an operating company of Fresenius. The FDA has assigned a target action date in the ...
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and ...
The Fresenius healthcare group is continuously expanding its range of innovative products. A new laboratory and office building with a technical center called KabiLab D20 is being built at ...
In August 2022, Fresenius Kabi and Insud Pharma entered into an agreement whereby ... please visit our website (www.mabxience.com) or connect with us on LinkedIn.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results